IFS Advisors’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.46K Buy
+100
New +$5.68K ﹤0.01% 372
2023
Q1
– Sell
-200
Closed -$7.55K – 130
2022
Q4
$7.55K Hold
200
– – 0.01% 64
2022
Q3
$8K Hold
200
– – 0.01% 53
2022
Q2
$7K Hold
200
– – 0.02% 56
2022
Q1
$7K Hold
200
– – 0.01% 69
2021
Q4
$6K Buy
+200
New +$6.3K ﹤0.01% 83
2021
Q1
– Sell
-200
Closed -$11K – 79
2020
Q4
$11K Buy
+200
New +$10K 0.01% 99

Other funds holding IONS

IFS Advisors's IONS Position: Q3 2026 in Review

IFS Advisors opened a new position in Ionis Pharmaceuticals (IONS) in Q3 2026: 100 shares worth $4.46K. The stake represents ﹤0.01% of the portfolio and ranks #372 among its holdings. This is a return to the name: IFS Advisors previously reported a position in IONS as recently as Q4 2022.

IFS Advisors first reported a position in IONS in Q4 2020 and has held it in 7 quarters since. The position peaked at $11K in Q4 2020. 464 funds tracked by Wall St. Rank hold IONS as of Q3 2026.

  • IFS Advisors held 100 shares of Ionis Pharmaceuticals worth $4.46K as of Q3 2026.
  • Ionis Pharmaceuticals was a new IFS Advisors position in Q3 2026.
  • Ionis Pharmaceuticals made up ﹤0.01% of IFS Advisors's portfolio in Q3 2026, its #372 holding.
  • IFS Advisors first reported a position in Ionis Pharmaceuticals in Q4 2020 and has held it in 7 quarters since.
  • IFS Advisors's Ionis Pharmaceuticals position peaked at $11K in Q4 2020.
  • 464 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.

Based on IFS Advisors's 13F filing for Q3 2026, filed 14 Oct 2026.